- Home
- MCRB vs HURC Comparison
MCRB vs HURC Comparison
Compare MCRB & HURC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- HURC
- Stock Information
- Founded
- MCRB 2010
- HURC 1968
- Country
- MCRB United States
- HURC United States
- Employees
- MCRB N/A
- HURC N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- HURC Industrial Machinery/Components
- Sector
- MCRB Health Care
- HURC Industrials
- Exchange
- MCRB Nasdaq
- HURC Nasdaq
- Market Cap
- MCRB 103.7M
- HURC 104.0M
- IPO Year
- MCRB 2015
- HURC N/A
- Fundamental
- Price
- MCRB $12.09
- HURC $20.08
- Analyst Decision
- MCRB Hold
- HURC
- Analyst Count
- MCRB 4
- HURC 0
- Target Price
- MCRB $73.67
- HURC N/A
- AVG Volume (30 Days)
- MCRB 109.0K
- HURC 33.0K
- Earning Date
- MCRB 08-12-2025
- HURC 09-05-2025
- Dividend Yield
- MCRB N/A
- HURC N/A
- EPS Growth
- MCRB N/A
- HURC N/A
- EPS
- MCRB 8.98
- HURC N/A
- Revenue
- MCRB N/A
- HURC $183,634,000.00
- Revenue This Year
- MCRB N/A
- HURC N/A
- Revenue Next Year
- MCRB N/A
- HURC N/A
- P/E Ratio
- MCRB $1.50
- HURC N/A
- Revenue Growth
- MCRB N/A
- HURC N/A
- 52 Week Low
- MCRB $6.53
- HURC $13.19
- 52 Week High
- MCRB $30.60
- HURC $23.76
- Technical
- Relative Strength Index (RSI)
- MCRB 66.74
- HURC 74.01
- Support Level
- MCRB $10.67
- HURC $15.33
- Resistance Level
- MCRB $12.84
- HURC $21.46
- Average True Range (ATR)
- MCRB 1.09
- HURC 1.15
- MACD
- MCRB 0.34
- HURC 0.25
- Stochastic Oscillator
- MCRB 85.98
- HURC 75.16
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.